HCV on the threshold

Infections in Medicine

Volumn 16, Issue 2, 1999, Pages 92-94

  Sherman, Alex ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatitis C virus (HCV); Interferon; Ribavirin

Indexed keywords

HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; REVIEW; UNITED STATES; VIRUS DIAGNOSIS;

EID: 0033014822     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Alter MJ, Mares A, Hadler SC, et al: The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 125:133-139, 1987.
2. Donahue JG, Nelson KE, Munoz A, et al: Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Md. Am J Epidemiol 134:1206-2111, 1991.
3. Alter MJ: Residual risk of transfusion-associated hepatitis. NIH Consensus Development Conference on Infectious Disease Testing for Blood Transfusions. Bethesda, Md., 1995, pp 23-27.
4. Conry-Cantilena C, VanRaden M, Gibble J, et al: Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334:1691-1696, 1996.
5. Everhart JE, Di Bisceglie AM, Murray LM, et al: Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 112:544-545, 1990.
6. Eyster ME, Alter HJ, Aledort LM, et al: Heterosexual cotransmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 115:764-768, 1991.
7. Gordon SC, Patel AH, Kulesza GW, et al: Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 87:1849-1851, 1987.
8. Tong MJ, Lai PPC, Hwang SJ, et al: Evaluation of sexual transmission in patients with hepatitis C infection. Clin Diagn Virol 3:39-47, 1995.
9. Westjal R, Widell A, Mansson AS, et al: Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 117:887-890, 1992.
10. Ohto H, Terazawa S, Sasaki N, et al: Transmission of hepatitis C virus from mothers to infants. N Engl J Med 33:744-750, 1994.
11. Ni YH, Lin HH, Chen PJ, et al: Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immunodeficiency virus coinfection. J Hepatol 20:641-645, 1994.
12. Giancchino R, Picciotto A, Tasso L, et al: Vertical transmission of hepatitis C. Lancet 345:1122-1123, 1995.
13. Zanetti AR, Tanzi E, Paccagnini S, et al: Mother-to-infant transmission of hepatitis C virus. Lancet 345:289-291, 1995.
14. Granovsky MO, Minkoff HL, Tess BH, et al: Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 102:355-359, 1998.
15. Thomas DL, Villano SA, Riester KA, et al: Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers: Women and Infants Transmission Study. J Infect Dis 177:1480-1488, 1998.
16. Centers for Disease Control and Prevention: Recommendations for follow-up of health care workers after occupational exposure to hepatitis C virus. MMWR 46:603-606, 1997.
17. Shapiro CN: Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 75:1047-1056, 1995.
18. Centers for Disease Control and Prevention: Risk of acquiring hepatitis C for health care workers and recommendations for prophylaxis and follow-up after occupational exposure. Hepatitis Surveillance Report No. 56. Atlanta, 1995.
19. Puro V, Petrosillo N, Ippolito G, et al: Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control 23:273-277, 1995.
20. Hoofnagle JH, Bisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 336:347-356, 1997.
21. Tine F, Magrin S, Craxi A, et al: Interferon for non-A, non-B chronic hepatitis: A meta analysis of randomized clinical trials. J Hepatol 13:192-199, 1991.
22. Poynard T, Bedossa P, Chevallier M, et al: A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457-1462, 1995.
23. Lin R, Roach E, Zimmerman M, et al: Interferon alfa-2b for chronic hepatitis C: Effects of dose increment and duration of treatment on response rates: Results of the first multicentre Australian trial. J Hepatol 23:487-496, 1995.
24. Carithers RL Jr, Emerson SS: Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials. Hepatology 26(suppl 1): S83-S88, 1997.
25. Davis GL, Esteban-Mur R, Rustgi V, et al: Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 339:1493-1499, 1998.
26. McHutchison JG, Gordon SC, Schiff ER, et al: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339:1485-1492, 1998.